Clinical Trials Browser

Phase 2 × Active not recruiting × aldesleukin × Clear all

NCT00338377 2026-02-23

Lymphodepletion Plus Adoptive Cell Transfer With or Without Dendritic Cell Immunization in Patients With Metastatic Melanoma

Phase 2 Active not recruiting

1,230 enrolled

Dermatologic

Melanoma, Meningeal Neoplasms

NCT01697527 2025-11-24

Gene and Vaccine Therapy in Treating Patients With Advanced Malignancies

Phase 2 Active not recruiting

6 enrolled

Tumor-Agnostic

Neoplasms

NCT03449108 2025-11-21

LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas

Phase 2 Active not recruiting

30 enrolled

BreastEndocrineGynecologicHead & NeckSarcoma

Bone Neoplasms, Ovarian Neoplasms, Sarcoma, Osteosarcoma, Giant Cell Tumor of Bone, Histiocytoma, Malignant Fibrous, Triple Negative Breast Neoplasms, Thyroid Carcinoma, Anaplastic

NCT01857934 2025-11-17

Therapy for Children With Advanced Stage Neuroblastoma

Phase 2 Active not recruiting

153 enrolled 12 charts

CNS

Neuroblastoma

NCT02306954 2025-03-10

Study of High Dose Interleukin-2 (IL-2) and Stereotactic Body Radiation (SBRT) in Patients With Metastatic Renal Cancer

Phase 2 Active not recruiting

84 enrolled

Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT03501381 2023-09-01

High Dose IL 2 and Entinostat in RCC

Phase 2 Active not recruiting

46 enrolled

Genitourinary

Carcinoma, Renal Cell

NCT00553618 2021-10-29

DTIC

Phase 2 Active not recruiting

160 enrolled

Dermatologic

Melanoma